Alignment Healthcare Inc. (ALHC)
NASDAQ: ALHC
· Real-Time Price · USD
17.31
-0.08 (-0.46%)
At close: Sep 25, 2025, 3:59 PM
17.31
0.00%
After-hours: Sep 25, 2025, 04:20 PM EDT
-0.46% (1D)
| Bid | 17.25 |
| Market Cap | 3.43B |
| Revenue (ttm) | 3.34B |
| Net Income (ttm) | -50.95M |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -64.11 |
| Forward PE | 852 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 17.35 |
| Volume | 2,883,993 |
| Avg. Volume (20D) | 3,827,823 |
| Open | 17.38 |
| Previous Close | 17.39 |
| Day's Range | 17.01 - 17.49 |
| 52-Week Range | 9.15 - 21.06 |
| Beta | 1.18 |
| Ex-Dividend Date | n/a |
About ALHC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALHC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALHC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAlignment Healthcare Inc. is scheduled to release its earnings on
Oct 28, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+6%
TransMedics Group shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
+10.36%
Alignment Healthcare shares are trading higher after the company reported better-than-expected Q2 financial results, issued Q3 sales guidance above estimates. and raised its FY25 sales guidance.
2 months ago · seekingalpha.com
Alignment Healthcare: Secular Growth Opportunity And Scalable Business ModelAlignment Healthcare is well-positioned for growth, benefiting from an aging U.S. population and increasing demand for high-quality senior healthcare services. Strong membership growth and high CMS st...
2 months ago · seekingalpha.com
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net IncomeA majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecas...
